tiprankstipranks
Virpax Pharmaceuticals (VRPX)
NASDAQ:VRPX
US Market

Virpax Pharmaceuticals (VRPX) Income Statement

Compare
197 Followers

Virpax Pharmaceuticals Income Statement

Last quarter (Q3 2024), Virpax Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Virpax Pharmaceuticals's net income was $-2.01M. See Virpax Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 15.69M$ 21.85M$ 12.03M$ 4.20M$ 3.18M
Depreciation and Amortization
$ 500.28K$ 18.35M$ 12.03M$ 4.20M$ 3.18M
EBITDA
$ -15.19M$ 0.00$ 0.00$ -4.19M$ 0.00
Operating Income
$ -15.69M$ -21.85M$ -12.03M$ -4.20M$ -3.18M
Other Income/Expenses
$ 500.28K$ 194.41K$ -30.56K$ -143.93K$ -124.64K
Pretax Income
$ -15.19M$ -21.65M$ -12.06M$ -4.34M$ -3.31M
Net Income
$ -15.19M$ -21.46M$ -12.15M$ -4.49M$ -3.43M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -12.97$ -18.32$ -10.37$ -9.07$ -6.58
Diluted EPS
$ -12.97$ -18.32$ -10.37$ -9.07$ -6.58
Weighted Average Shares Outstanding
1.17M 1.17M 1.17M 494.51K 521.51K
Weighted Average Shares Outstanding (Diluted)
1.17M 1.17M 1.17M 494.51K 521.51K
Currency in USD

Virpax Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis